Correlation Between Eli Lilly and Mayne Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Mayne Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Mayne Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Mayne Pharma Group, you can compare the effects of market volatilities on Eli Lilly and Mayne Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Mayne Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Mayne Pharma.

Diversification Opportunities for Eli Lilly and Mayne Pharma

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Eli and Mayne is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Mayne Pharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mayne Pharma Group and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Mayne Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mayne Pharma Group has no effect on the direction of Eli Lilly i.e., Eli Lilly and Mayne Pharma go up and down completely randomly.

Pair Corralation between Eli Lilly and Mayne Pharma

Considering the 90-day investment horizon Eli Lilly and is expected to under-perform the Mayne Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Eli Lilly and is 1.38 times less risky than Mayne Pharma. The stock trades about -0.08 of its potential returns per unit of risk. The Mayne Pharma Group is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  300.00  in Mayne Pharma Group on September 13, 2024 and sell it today you would earn a total of  10.00  from holding Mayne Pharma Group or generate 3.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Eli Lilly and  vs.  Mayne Pharma Group

 Performance 
       Timeline  
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of sluggish performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Mayne Pharma Group 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Mayne Pharma Group are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Mayne Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Eli Lilly and Mayne Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eli Lilly and Mayne Pharma

The main advantage of trading using opposite Eli Lilly and Mayne Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Mayne Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mayne Pharma will offset losses from the drop in Mayne Pharma's long position.
The idea behind Eli Lilly and and Mayne Pharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bonds Directory
Find actively traded corporate debentures issued by US companies
Transaction History
View history of all your transactions and understand their impact on performance